|
Market Closed -
Australian S.E.
01:16:26 2026-07-23 EDT
|
5-day change | 1st Jan Change | ||
| 0.0110 AUD | -.--% |
|
-.--% | -54.17% |
| 06-25 | Nexalis Therapeutics Ltd Announces Board Changes, Effective June 25, 2026 | CI |
| 05-27 | Nexalis Therapeutics signs funding partnership with Point8 Capital to replace existing facility | RE |
| Market Cap | 2.78M 1.99M 1.71M 1.6M 1.46M 2.76M 190M 18.86M 7.34M 95.78M 7.48M 7.31M 317M | P/E 2024 |
-6.17x | P/E 2025 | -3.2x |
|---|---|---|---|---|---|
| Enterprise Value | 3.09M 2.21M 1.89M 1.77M 1.62M 3.06M 211M 20.92M 8.14M 106M 8.29M 8.11M 352M | EV / Sales 2024 |
18.2x | EV / Sales 2025 | 6.13x |
| Free-Float |
30.93% | Yield 2024 * |
-
| Yield 2025 | - |
| 3 months | -56.00% | ||
| 6 months | -60.71% | ||
| Current year | -54.17% |
| Current year | 0.01 |  | 0.03 |
| 1 year | 0.01 | | 0.04 |
| 3 years | 0.01 | | 0.05 |
| 5 years | 0.01 | | 0.13 |
| 10 years | 0.01 | | 0.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Darryl Davies
CEO | Chief Executive Officer | - | 2022-09-26 |
Greg Hammond
DFI | Director of Finance/CFO | - | - |
Rob Jenny
CTO | Chief Tech/Sci/R&D Officer | - | 2022-09-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Darryl Davies
BRD | Director/Board Member | - | 2026-06-24 |
Sean Williams
CHM | Chairman | - | 2021-07-26 |
James Barrie
BRD | Director/Board Member | - | 2026-05-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -68.57% | -75.56% | 1.99M | |
| -0.15% | +2.49% | +2.66% | +24.84% | 51.65B | |
| -0.09% | -2.14% | +492.60% | +537.84% | 45.31B | |
| -0.32% | +8.08% | +37.97% | +18.45% | 42.7B | |
| +1.18% | +1.96% | +21.95% | +89.69% | 42.79B | |
| -2.27% | -3.02% | +14.22% | +51.50% | 32.87B | |
| -0.96% | +4.03% | +31.55% | +136.34% | 17.14B | |
| +0.41% | +1.66% | - | - | 16.61B | |
| +0.16% | +5.01% | +13.21% | +31.00% | 15.01B | |
| -0.31% | +6.61% | +81.37% | +48.53% | 14.21B | |
| Average | -0.24% | +2.67% | +69.66% | +95.85% | 27.83B | |
| Weighted average by Cap. | -0.22% | +2.74% | +104.63% | +135.51% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 402K 287K 246K 231K 211K 398K 27.4M 2.72M 1.06M 13.83M 1.08M 1.06M 45.79M | 986K 706K 605K 567K 518K 977K 67.28M 6.68M 2.6M 33.94M 2.65M 2.59M 112M |
| Net income | -1.21M -865K -741K -695K -635K -1.2M -82.48M -8.19M -3.19M -41.61M -3.25M -3.18M -138M | -1.62M -1.16M -992K -930K -849K -1.6M -110M -10.97M -4.27M -55.7M -4.35M -4.25M -184M |
| Net Debt | -161K -115K -98.61K -92.4K -84.4K -159K -10.97M -1.09M -424K -5.53M -432K -423K -18.33M | 304K 218K 187K 175K 160K 301K 20.76M 2.06M 803K 10.47M 818K 800K 34.69M |
Employees
-
- Stock Market
- Stocks
- NX1 Stock
Select your edition
All financial news and data tailored to specific country editions
